Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -2.92% | 158.01 | 0.7% | $1349.36m | |
| PFE | Pfizer Inc. | -0.89% | 33.52 | 0.9% | $1231.01m | |
| BMY | Bristol-Myers Squibb Co. | -1.35% | 61.26 | 1.0% | $864.73m | |
| MRK | Merck & Co., Inc. | -2.73% | 72.58 | 0.7% | $812.99m | |
| ABBV | AbbVie, Inc. | 0.28% | 107.63 | 1.9% | $810.79m | |
| LLY | Eli Lilly & Co. | 0.43% | 204.69 | 1.1% | $785.50m | |
| AZN | AstraZeneca Plc | -1.08% | 48.38 | 1.2% | $514.48m | |
| GSK | GlaxoSmithKline Plc | -2.24% | 33.61 | 0.2% | $264.35m | |
| NVS | Novartis AG | -0.87% | 85.96 | 0.2% | $189.07m | |
| SNY | Sanofi | 0.20% | 45.89 | 0.2% | $168.76m | |
| VTRS | Viatris, Inc. | -1.33% | 14.85 | 0.0% | $142.39m | |
| VERU | Veru, Inc. | -3.22% | 13.82 | 0.0% | $115.13m | |
| CVAC | CureVac NV | 1.43% | 94.30 | 0.0% | $107.78m | |
| VYNE | VYNE Therapeutics, Inc. | -5.45% | 7.46 | 0.0% | $94.74m | |
| NVO | Novo Nordisk A/S | -1.47% | 71.28 | 0.1% | $91.66m |
Company Profile
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.